Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,099 public trials 2,041 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Phase II Study of Age-Adjusted Rituximab, Bendamustine, Cytarabine as Induction Therapy in Older Patients With MCL

NCT01662050

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • A.O. Policlinico Consorziale Bari, BA, Italy
  • IRCCS Ospedale Oncologico Bari, BA, Italy
  • A.O. Spedali Civili Brescia, BS, Italy
  • U.O.C. Ematologia Ospedale "San Nicola Pellegrino" ASL BAT Trani, BT, Italy
View all 56 locations
View Trial Details
Completed

Short Term Intensified Chemo-immunotherapy in HIV-positive Patients With Burkitt Lymphoma

NCT01516593

Conditions
Burkitt Lymphoma, Burkitt's Lymphoma, DNA Virus Infections, +16 more
Locations
  • Oncologia Medica A - Centro di Riferimento Oncologico Aviano (PN), Italy
  • Ematologia - A.O. Spedali Civili Brescia, Italy
  • Dip. Oncoematologia - Fondazione Centro San Raffaele del Monte Tabor Milan, Italy
  • S.C. Oncologia Medica - Ospedale San Paolo Milan, Italy
View Trial Details
Completed

Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia

NCT01005368

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations
  • Kaiser Permanente Medical Office -Vandever Medical Office San Diego, California, United States
  • Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States
  • CCOP - Christiana Care Health Services Newark, Delaware, United States
  • Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington D.C., District of Columbia, United States
View all 35 locations
View Trial Details
Completed

Filanesib (ARRY-520) in Combination With Pomalidomide and Dexamethasone for Relapsed/Refractory (R/R) Multiple Myeloma (MM) Patients

NCT02384083

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Instoitut Català d'Oncologia Badalona, Spain
  • Hospital Clinico Universitario Barcelona, Spain
  • Hospital Doce de Octubre Madrid, Spain
  • Hospital Morales Messeguer Murcia, Spain
View Trial Details

Related conditions